Health Catalyst, Inc. (HCAT)
HCAT Stock Price Chart
Explore Health Catalyst, Inc. interactive price chart. Choose custom timeframes to analyze HCAT price movements and trends.
HCAT Company Profile
Discover essential business fundamentals and corporate details for Health Catalyst, Inc. (HCAT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
25 Jul 2019
Employees
1.50K
Website
https://www.healthcatalyst.comCEO
Daniel D. Burton
Description
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
HCAT Financial Timeline
Browse a chronological timeline of Health Catalyst, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 5 Nov 2025
EPS estimate is $0.07, while revenue estimate is $75.05M.
Earnings released on 7 Aug 2025
EPS came in at $0.04 surpassing the estimated $0.03 by +33.33%, while revenue for the quarter reached $80.72M , missing expectations by -5.19%.
Earnings released on 7 May 2025
EPS came in at $0.01 matching the estimated $0.01, while revenue for the quarter reached $79.41M , beating expectations by +0.32%.
Earnings released on 26 Feb 2025
EPS came in at $0.04 falling short of the estimated $0.11 by -63.64%, while revenue for the quarter reached $79.61M , beating expectations by +0.02%.
Earnings released on 6 Nov 2024
EPS came in at $0.07 falling short of the estimated $0.10 by -30.00%, while revenue for the quarter reached $76.35M , missing expectations by -5.37%.
Earnings released on 7 Aug 2024
EPS came in at $0.12 surpassing the estimated $0.09 by +33.33%, while revenue for the quarter reached $75.90M , beating expectations by +1.20%.
Earnings released on 9 May 2024
EPS came in at $0.05 surpassing the estimated $0.03 by +79.02%, while revenue for the quarter reached $74.72M , missing expectations by -0.10%.
Earnings released on 22 Feb 2024
EPS came in at $0.02 surpassing the estimated $0.00 by +2.72K%, while revenue for the quarter reached $75.08M , beating expectations by +2.02%.
Earnings released on 2 Nov 2023
EPS came in at $0.03 surpassing the estimated $0.01 by +275.47%, while revenue for the quarter reached $73.77M , beating expectations by +0.56%.
Earnings released on 8 Aug 2023
EPS came in at $0.05 surpassing the estimated $0.00 by +1.45K%, while revenue for the quarter reached $73.21M , beating expectations by +0.80%.
Earnings released on 9 May 2023
EPS came in at $0.05 surpassing the estimated $0.02 by +222.79%, while revenue for the quarter reached $73.87M , beating expectations by +3.69%.
Earnings released on 28 Feb 2023
EPS came in at -$0.05 surpassing the estimated -$0.10 by +50.00%, while revenue for the quarter reached $69.16M , beating expectations by +1.32%.
Earnings released on 8 Nov 2022
EPS came in at -$0.13 surpassing the estimated -$0.20 by +35.00%, while revenue for the quarter reached $68.35M , beating expectations by +2.30%.
Earnings released on 4 Aug 2022
EPS came in at -$0.03 surpassing the estimated -$0.11 by +72.73%, while revenue for the quarter reached $70.63M , beating expectations by +1.08%.
Earnings released on 10 May 2022
EPS came in at -$0.06 surpassing the estimated -$0.08 by +25.00%, while revenue for the quarter reached $68.09M , beating expectations by +3.15%.
Earnings released on 1 Mar 2022
EPS came in at -$0.19 surpassing the estimated -$0.21 by +9.52%, while revenue for the quarter reached $64.72M , beating expectations by +2.53%.
Earnings released on 9 Nov 2021
EPS came in at -$0.18 surpassing the estimated -$0.22 by +18.18%, while revenue for the quarter reached $61.74M , beating expectations by +2.10%.
Earnings released on 5 Aug 2021
EPS came in at -$0.80 falling short of the estimated -$0.14 by -470.24%, while revenue for the quarter reached $59.63M , beating expectations by +4.46%.
Earnings released on 6 May 2021
EPS came in at -$0.06 surpassing the estimated -$0.13 by +53.85%, while revenue for the quarter reached $55.85M , missing expectations by -30.56%.
Earnings released on 25 Feb 2021
EPS came in at -$0.16 surpassing the estimated -$0.18 by +11.11%, while revenue for the quarter reached $53.28M , missing expectations by -13.64%.
Earnings released on 10 Nov 2020
EPS came in at -$0.21 surpassing the estimated -$0.27 by +22.22%, while revenue for the quarter reached $47.19M , missing expectations by -18.18%.
HCAT Stock Performance
Access detailed HCAT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.